YoY Rev at 1751cr vs 1181cr
48%
QoQ Rev at 1751cr Vs 1618cr8%
FY Rev at 6015cr vs 4534cr 32%
YoY PAT at 163cr vs 154cr5.9%
QoQ PAT at 163cr Vs 156cr4.4%
FY PAT at 514cr vs 522Cr
1.5%
Q4 EPS at 14.8 Rs vs 14.03 Rs
FY22 EPS at Rs. 46.7 vs 47.5
✓ OCF 553 Cr Vs. 634 Cr in YoY
✓EBITDA margin: 13.3% Vs. 18.1% in YoY, EBITDA: INR 233 Cr Vs. 214 Cr in YoY up by 8.9%
✓ Current PE: 24, Forward PE: 20
✓ ROE: 20%, ROCE: 17%
Highlights:
✓ Recommended Final Dividend of INR 16/- per equity share (i.e 320 %) on par value of Rs. 5 per share, for the finanacial year 2022-23.
View: Overall result is OK. Although Cost is jump by 62% in YoY and main reason for profit Hit in this quarter. Regular dividend paying company. Company operates through eight strategic business units: Aerospace & Defense; Transportation; Industrial, energy and natural resources; Semiconductor, Internet of things and Analytics; Medical and Healthcare; Utilities & Geospatial; Communications and Design-led-manufacturing (Cyient DLM). Diversified business scenario.
